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Introduction {#sec1}
============

At excitatory synapses of hippocampal neurons, the group I metabotropic glutamate receptors (mGluRs) mGluR1 and mGluR5 critically modulate synaptic transmission and plasticity ([@bib45]). The contribution of mGluRs to glutamatergic signaling underlies cognitive functions, and disrupted mGluR signaling has been implicated in neurological disorders, including autism spectrum disorders (ASDs) ([@bib30]). To prevent overstimulation, activated mGluRs are rapidly desensitized and internalized via clathrin-mediated endocytosis ([@bib12]). Despite the importance of controlled receptor trafficking at synapses, we know little about the mechanisms that control the endocytosis and recycling of synaptic mGluRs. The endocytosis of postsynaptic membrane proteins preferentially takes place at endocytic zones (EZs) ([@bib44]). EZs are stable clathrin assemblies coupled to the postsynaptic density (PSD) via interactions with Homer1b/c and Dynamin3 ([@bib5], [@bib29], [@bib43]). Disruption of the PSD-EZ coupling reduces the synaptic population of the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPARs), and prevents plasticity-induced receptor insertion ([@bib41]). However, whether mGluRs are locally endocytosed through EZs and recycle to the synaptic membrane remains untested.

The Shank family (Shank1, -2, and -3) is an integral part of the PSD, interacting with a multitude of synaptic proteins, as well as endocytic proteins, such as Dynamin2, Cortactin, Syndapin I, and Abp1 ([@bib24], [@bib35], [@bib36], [@bib39], [@bib42]). Moreover, abrogated mGluR signaling has been found in Shank mutant models ([@bib2], [@bib25], [@bib27], [@bib48]), but how Shank proteins control mGluR function remains unknown. We hypothesized that Shank proteins recruit components of the endocytic machinery to facilitate the local regulation of receptor internalization to control mGluR function. We found that agonist-induced internalization of mGluR5 is severely affected in Shank triple knockdown neurons and present evidence that mGluR5 is internalized through the EZ coupled to the PSD by Shank-mediated interactions. We propose that Shank proteins link the EZ to the PSD to control trafficking of synaptic membrane proteins and to balance the density of receptors at the membrane to modulate neuronal functioning.

Results {#sec2}
=======

Efficient Internalization and Intracellular Sorting of Activated mGluR5 {#sec2.1}
-----------------------------------------------------------------------

To test whether the activation of mGluR5 triggers endocytosis in hippocampal neurons, we live-labeled surface-expressed myc-mGluR5, and incubated neurons with the group I-specific agonist (*S*)-3,5-dihydroxyphenylglycine (DHPG). Surface expression of mGluR5 markedly decreased over time, which was best described by a single-exponential decay function with a rate constant of 0.077 ± 0.03 min^−1^, reaching a plateau at 42% ± 7% reduction ([Figures 1](#fig1){ref-type="fig"}A and 1B), consistent with previous reports ([@bib26]). Internalized mGluR5 puncta largely overlapped with the early and recycling endosome markers anti-EEA1, GFP-Rab5, GFP-Rab11, and mRFP-TfR, but much less with the late endosome marker GFP-Rab7 and the lysosomal marker GFP-LAMP1 (EEA1: 70% ± 3%, Rab5: 80% ± 3%, Rab11: 76% ± 3%, TfR: 77% ± 4%, Rab7: 38% ± 3%, LAMP1: 31% ± 5%, p \< 0.001; [Figures 1](#fig1){ref-type="fig"}C and 1D).Figure 1Efficient Agonist-Induced mGluR5 Internalization in Spines(A) Dendrite stained for surface expressed (red outline) and internalized (cyan outline) myc-mGluR5 before (top panels) and 30 min after (bottom panels) DHPG treatment. Scale bar, 5 μm.(B) Quantification of the ratio of surface over total myc-mGluR5 intensity at different time points after DHPG stimulation (n = 8--20). Dashed line represents single exponential fit.(C) Co-localization of internalized myc-mGluR5 (cyan) and indicated endosomal and lysosomal markers (red). The arrowheads indicate examples of overlapping puncta. Scale bar, 5 μm.(D) Quantification of overlap between internalized myc-mGluR5 puncta and indicated markers (EEA1: n = 10, Rab5: n = 10, Rab11: n = 8, TfR: n = 10, Rab7: n = 9, LAMP1: n = 9).(E) Schematic of SEP-tag fused to mGluR5.(F) Live-cell time-lapse imaging of a dendrite expressing SEP-mGluR5 stimulated with DHPG at t = 0. Scale bar, 5 μm.(G and H) Quantification of SEP-mGluR5 intensity over a 30-min period comparing the application of vehicle (black; n = 8) and DHPG (gray; n = 6) at t = 0 in spines (G) and dendrites (H).(I and J) Quantification of SEP-mGluR5 intensity in spines over time after DHPG stimulation comparing control neurons (gray; n = 6) with neurons pre-treated with dynasore (orange; n = 6) (I) and neurons co-transfected with Dyn2 (gray; n = 6) with neurons co-transfected with Dyn2-K44A (orange; n = 6) (J).(K and L) Quantification of SEP-mGluR5 intensity in spines over time without the addition of DHPG comparing control neurons (black; n = 6) with neurons pre-treated with dynasore (orange; n = 8) (K) and neurons co-transfected with Dyn2 (gray; n = 6) with neurons co-transfected with Dyn2-K44A (orange; n = 6) (L).Data are represented as means ± SEMs. ^∗^p \< 0.05, ^∗∗∗^p \< 0.001.

To image the surface expressed pool of mGluR5 in live cells, we tagged mGluR5 with an extracellular super-ecliptic pHluorin (SEP) tag ([Figure 1](#fig1){ref-type="fig"}E). We confirmed that the fluorescence of this GFP variant is quenched at low pH, such as in endocytic vesicles, and only becomes fluorescent at neutral pH ([Figure S1](#mmc1){ref-type="supplementary-material"}A). Application of DHPG induced a rapid decrease in SEP-mGluR5 intensity from dendritic spines (DHPG: 39.7% ± 2.2% at t = 28 min, vehicle: 14.0% ± 1.6%, p \< 0.001; [Figures 1](#fig1){ref-type="fig"}F and 1G). Imaging at reduced frame rates revealed no significant difference in observed signal reduction both after vehicle (15.8% ± 3.1%; [Figure S1](#mmc1){ref-type="supplementary-material"}B) and DHPG application (37.8% ± 3.5%; [Figure S1](#mmc1){ref-type="supplementary-material"}C). Thus, the observed reduction of SEP-mGluR5 intensity in unstimulated spines is not due to photobleaching, but likely reflects ongoing receptor internalization, which is consistent with other studies that estimated ∼20% agonist-independent internalization over 30 min ([@bib18], [@bib26]). In some but not all experiments, we noted that DHPG or vehicle application induced a transient increase in SEP-mGluR5 fluorescence intensity (e.g., [Figure 1](#fig1){ref-type="fig"}G). If it was observed, then it was independent of the experimental conditions and could be attributed to the opening of the imaging chamber, briefly affecting the pH of the imaging buffer.

In dendrites, the DHPG-induced decrease in SEP-mGluR5 signal was not significantly different from the vehicle control (DHPG: 26.0% ± 4.7%, vehicle: 18.1% ± 2.6%; [Figure 1](#fig1){ref-type="fig"}H). However, these measurements do not directly measure endocytosis, but also reflect ongoing recycling and lateral exchange of receptors on the membrane. To more directly determine whether mGluR5 can be internalized in dendrites, we tagged mGluR5 with an extracellular HaloTag to label with AcidiFluor ORANGE, which only fluoresces at a low pH (pH 5--6) ([@bib22]) ([Figure S1](#mmc1){ref-type="supplementary-material"}D). The application of DHPG induced distinct, local increases in Halo-mGluR5 signal intensity, reflecting the acidification of Halo-mGluR5 containing endocytic vesicles, both in spines and dendrites ([Figures S1](#mmc1){ref-type="supplementary-material"}E--S1H).

To test whether Dynamin activity is required for agonist-induced mGluR5 internalization in spines, we treated neurons with dynasore, a potent inhibitor of Dynamin GTPase activity ([@bib33]) before the addition of DHPG. Dynasore significantly reduced DHPG-induced mGluR5 internalization in spines (control: 46.9% ± 5.1%, dynasore: 20.1% ± 6.3%, p \< 0.05; [Figure 1](#fig1){ref-type="fig"}I). Moreover, the expression of a dominant-negative form of Dynamin2 (Dyn2), Dynamin2-K44A (Dyn2-K44A), also reduced the DHPG-induced internalization of mGluR5 in spines (Dyn2: 39.8% ± 4.3%, Dyn2-K44A: 18.0% ± 5.5%, p \< 0.05; [Figure 1](#fig1){ref-type="fig"}J). The slow decrease in the fluorescence intensity of SEP-mGluR5 observed in spines without the application of DHPG was similar in dynasore-treated neurons and neurons expressing Dyn2-K44A, and was not different from control neurons ([Figures 1](#fig1){ref-type="fig"}K and 1L). In dendrites, the decrease in SEP-mGluR5 signal, in both unstimulated and DHPG-stimulated neurons, was not affected by dynasore or the expression of Dyn2-K44A ([Figures S1](#mmc1){ref-type="supplementary-material"}I--S1L), suggesting that internalization in dendrites is Dynamin-independent. These results indicate that in dendritic spines, receptor activation triggers rapid, Dynamin-dependent endocytosis of mGluR5 and that internalized receptors preferentially enter the recycling compartment.

Shank Proteins Are Required for Agonist-Induced Internalization of mGluR5 in Spines {#sec2.2}
-----------------------------------------------------------------------------------

To test whether Shank proteins contribute to mGluR5 endocytosis, we used a triple microRNA (miRNA) knockdown construct to simultaneously reduce the expression of Shank1, Shank2, and Shank3 (mirShank) ([Figure S2](#mmc1){ref-type="supplementary-material"}A) ([@bib32]). DHPG-induced mGluR5 internalization was significantly reduced in Shank triple knockdown (hereafter, Shank knockdown) neurons compared to control neurons (control: 43.8% ± 2.2%, mirShank: 24.8% ± 2.9%, p \< 0.001; [Figures 2](#fig2){ref-type="fig"}A and 2B). In contrast, in dendrites of both control and Shank knockdown neurons, DHPG-induced mGluR5 internalization was similar (control: 22.8% ± 2.9%, mirShank: 18.8% ± 3.5%, [Figure 2](#fig2){ref-type="fig"}C). DHPG-induced mGluR5 internalization in spines was completely restored to control levels by the re-expression of miRNA-resistant Shank1, SHANK2, or SHANK3 in Shank knockdown neurons (control: 35.3% ± 1.8%, mirShank: 10.4% ± 4.4%, mirShank::SHANK2: 36.4% ± 2.6%, mirShank::SHANK3: 36.4% ± 2.4%; [Figures 2](#fig2){ref-type="fig"}A and 2D; and control: 44.5% ± 3.3%, mirShank: 24.8% ± 2.7%, mirShank::Shank1: 43.4% ± 2.9%; [Figures S2](#mmc1){ref-type="supplementary-material"}B and S2C). We did not find a significant change in agonist-induced mGluR5 internalization in neurons overexpressing SHANK2 (control: 46.6% ± 4.0%, SHANK2 overexpressing \[OE\]: 39.5% ± 2.7%; [Figure 2](#fig2){ref-type="fig"}E), suggesting that endogenous Shank levels are sufficient to sustain the agonist-induced endocytosis of mGluR5. Also, SEP-mGluR5 intensity was unchanged over a period of 30 min in the absence of DHPG between control and Shank knockdown neurons in spines (control: 18.6% ± 1.7%, mirShank: 22.4% ± 2.8%; [Figure 2](#fig2){ref-type="fig"}F) and dendrites (control: 11.9% ± 2.7%, mirShank: 10.1% ± 3.9%; [Figure S2](#mmc1){ref-type="supplementary-material"}D). Similarly, the agonist-induced internalization of mGluR1 was also reduced in Shank knockdown neurons (control: 38.6% ± 3.4%, mirShank: 14.6% ± 5.8%, p \< 0.001; [Figure 2](#fig2){ref-type="fig"}G). Thus, agonist-induced internalization of mGluR1 and mGluR5 in spines is modulated by synaptic Shank scaffolds.Figure 2Shank Knockdown Reduces Agonist-Induced mGluR5 Internalization in Spines(A) Live-cell time-lapse images of SEP-mGluR5 before and after DHPG stimulation (added at t = 0 min) in control, mirShank, mirShank::SHANK2, mirShank::SHANK3, and SHANK2 overexpression (OE) neurons. The dendrites are color-coded for the fluorescence intensity of SEP-mGluR5. Scale bar, 5 μm.(B and C) Quantification of SEP-mGluR5 intensity over time after the addition of DHPG in spines (B) and dendrites (C) of control (gray; n = 29) and mirShank neurons (blue; n = 34).(D and E) Quantification of SEP-mGluR5 intensity in spines over time after the addition of DHPG comparing control (gray; n = 7), mirShank (blue; open circles; n = 8), and the mirShank::SHANK2 (n = 6) and mirShank::SHANK3 (n = 8) rescue neurons (shades of blue; closed circles) (D), and comparing control (gray; n = 4) and SHANK2 overexpression (OE; blue; n = 6) neurons (E).(F) Quantification of SEP-mGluR5 intensity in spines over time without the addition of DHPG comparing control (black; n = 5) and mirShank neurons (blue; n = 5).(G) Quantification of SEP-mGluR1 intensity in spines over time after the addition of DHPG in control (gray; n = 8) and mirShank neurons (blue; n = 6).Data are represented as means ± SEMs. ^∗∗∗^p \< 0.001.

Shank Proteins Couple the EZ to the PSD to Mediate the Local Endocytosis of mGluR5 {#sec2.3}
----------------------------------------------------------------------------------

We hypothesized that Shank proteins could play a central role in positioning the EZ by recruiting essential components of the endocytic machinery to the PSD ([Figure 3](#fig3){ref-type="fig"}A). To test this, we measured the fraction of PSDs associated with an EZ in control and Shank knockdown neurons. Consistent with previous reports ([@bib5], [@bib29]), we found that the majority of PSDs (72% ± 2%) were associated with an EZ marked by GFP-tagged clathrin light chain (GFP-CLC), but this was significantly reduced in Shank knockdown neurons (44% ± 2%, p \< 0.001; [Figures 3](#fig3){ref-type="fig"}B and 3C). The density of GFP-CLC puncta along the dendrite was not different between control and Shank knockdown neurons ([Figure S3](#mmc1){ref-type="supplementary-material"}A). Also, immunolabeled clathrin puncta were less frequently associated with synapses labeled with anti-Homer1b/c in Shank knockdown neurons compared to control neurons (untransfected: 72% ± 3%, control: 78% ± 3%, mirShank: 39% ± 5%; [Figure 3](#fig3){ref-type="fig"}D). The synaptic distribution of Homer1c-mCherry was not altered in Shank knockdown neurons ([Figures S3](#mmc1){ref-type="supplementary-material"}B--S3D).Figure 3Shanks Couple the EZ to the PSD to Control mGluR5 Trafficking in Spines(A) Domain structure of SHANK2. Proline-rich binding motifs for Homer1b/c, Dynamin2, and Cortactin are indicated.(B) Representative images of dendrites co-expressing GFP-CLC (cyan) and Homer1c-mCherry (red) in control and mirShank neurons. Indicated are examples of EZ^+^ (filled arrowhead) and EZ^−^ (open arrowheads) PSDs. Scale bar, 5 μm.(C) Quantification of the percentage of PSDs associated with a GFP-CLC marked EZ in control (n = 15) and mirShank (n = 15) neurons.(D) Quantification of PSDs associated with endogenous anti-clathrin in untransfected (n = 6) and transfected control (n = 6) and mirShank (n = 5) neurons.(E) Representative images of dendrites co-expressing mCherry-tagged SHANK2 rescue constructs (red) and GFP-CLC (cyan). Scale bar, 5 μm.(F) Quantification of the percentage of EZ^+^ PSDs in neurons co-expressing mCherry-tagged SHANK2 rescue constructs (WT: n = 14, ΔPDZ: n = 10, ΔDYN: n = 14, ΔCOR: n = 11, P1035L: n = 15, T1127M: n = 11, LPdup: n = 13).(G) Representative images showing internalized myc-mGluR5 (cyan) puncta 30 min after the application of DHPG in dendrites co-expressing Homer1c-mCherry (red) as a PSD marker, in control and mirShank neurons. Indicated are examples of internalized mGluR5 puncta-positive PSDs (filled arrowhead) and mGluR5 puncta-negative PSDs (open arrowheads). Scale bar, 5 μm.(H) Quantification of the percentage of internalized mGluR5 puncta-positive PSDs in control (n = 8) and mirShank (n = 8) neurons.(I) Representative images of dendrites co-expressing mCherry-tagged SHANK2 rescue constructs (red) and internalized myc-mGluR5 (cyan) 30 min after the application of DHPG. Scale bar, 5 μm.(J) Quantification of the percentage of internalized mGluR5 puncta-positive PSDs in neurons co-expressing mCherry-tagged SHANK2 rescue constructs (WT: n = 8, ΔPDZ: n = 7, ΔDYN: n = 12, ΔCOR: n = 9, P1035L: n = 9, T1127M: n = 14, LPdup: n = 8).(K) Representative image of recycled myc-mGluR5 (right panel) at EZ^+^ PSDs (white circles) and at EZ^−^ PSDs (white dashed circles). EZs are marked by GFP-CLC (cyan) and PSDs are marked by mCherry-SHANK3 (red) (left panel). Scale bar, 2 μm.(L) Quantification of the signal intensity of recycled myc-mGluR5 at EZ^−^ and EZ^+^ PSDs after 30 (n = 6) and 60 (n = 9) min of recycling. Data are normalized to myc-mGluR5 intensity at t = 0 min.Data are represented as means ± SEMs. ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001.

To test whether specific interaction motifs in SHANK2 are required for coupling the EZ to the PSD, we determined the fraction of EZ-positive (EZ^+^) PSDs in Shank knockdown neurons co-expressing miRNA-resistant wild-type (WT) SHANK2 (mirShank::SHANK2-WT; WT) and mutant forms of SHANK2 that lack the Dynamin2 (mirShank::SHANK2-ΔDYN; ΔDYN), Cortactin (mirShank::SHANK2-ΔCOR; ΔCOR), or Homer1b/c (mirShank::SHANK2-P1035L; P1035L) bindings sites. All of the mutants were effectively targeted to the PSD and did not alter synapse density ([Figures S3](#mmc1){ref-type="supplementary-material"}E--S3G), and were used as a marker of the PSD. Whereas re-expression of SHANK2-WT completely restored the fraction of EZ^+^ PSDs to control levels, the Dynamin2, Cortactin, or Homer1c binding site mutants were unable to rescue this (WT: 66% ± 3%, ΔDYN: 40.1% ± 3%, ΔCOR: 35.3% ± 3%, P1035L: 42.2% ± 2%, p \< 0.001; [Figures 3](#fig3){ref-type="fig"}E and 3F). However, complete removal of the SHANK2 PDZ domain (ΔPDZ) did not alter the ability of SHANK2 to rescue the fraction of EZ^+^ PSDs (66.1% ± 2%, n = 10; [Figures 3](#fig3){ref-type="fig"}E and 3F). Also, the overall density of GFP-CLC puncta in dendrites was not different between conditions ([Figure S3](#mmc1){ref-type="supplementary-material"}H). Thus, these data indicate that SHANK2 binding to Homer1b/c, Cortactin, and Dynamin2 contribute to positioning the EZ close to the PSD. Similar to SHANK2, re-expression of Shank1 and SHANK3 completely restored the fraction of EZ^+^ PSDs (Shank1: 70.3% ± 3%, SHANK2: 73.6% ± 2%, SHANK3: 72.9% ± 2%; [Figures S3](#mmc1){ref-type="supplementary-material"}I and S3J).

Among the numerous *de novo* mutations in the *SHANK2* gene identified in individuals with ASD, one particular nonsense mutation in *SHANK2* (T1127M) is located in the core of the Dynamin2 binding site ([@bib3]). We confirmed that this SHANK2 variant was efficiently targeted to synapses ([Figure S3](#mmc1){ref-type="supplementary-material"}E) ([@bib4]), but this single point mutation rendered SHANK2 unable to rescue the loss of EZ^+^ PSDs (45.2% ± 4%, p \< 0.001; [Figures 3](#fig3){ref-type="fig"}E and 3F). Another *de novo* mutation found in *SHANK2* in an individual with autism (L1008P1009dup; LPdup) was still able to rescue the loss of EZ-associated PSDs (66.9% ± 3%; [Figures 3](#fig3){ref-type="fig"}E and 3F).

To further test whether Shank proteins promote the local endocytosis of mGluR5, we determined the localization of internalized myc-mGluR5 with respect to the PSD. The fraction of synapses that overlapped with internalized mGluR5 puncta was significantly reduced in Shank knockdown neurons (control: 50.2% ± 4%, mirShank: 29.0% ± 3%, p \< 0.01; [Figures 3](#fig3){ref-type="fig"}G and 3H). In neurons re-expressing SHANK2-WT, this was completely restored, while SHANK2 mutants deficient in binding Homer1b/c, Cortactin, or Dynamin2 were unable to rescue this (WT: 55.8% ± 4%, ΔDYN: 32.1% ± 2%, ΔCOR: 35.7% ± 5%, P1035L: 33.4% ± 4%, p \< 0.001; [Figures 3](#fig3){ref-type="fig"}I and 3J). Also, in neurons re-expressing the ASD-associated SHANK2-T1127M mutant, there was a significant reduction in synapse-associated mGluR5 puncta (32% ± 4%, p \< 0.001; [Figures 3](#fig3){ref-type="fig"}I and 3J). However, re-expression of SHANK2-ΔPDZ and the ASD-associated SHANK2-LPdup mutant did not alter the ability of SHANK2 to rescue this (ΔPDZ: 56.4% ± 4%, LPdup: 61.8% ± 4%; [Figures 3](#fig3){ref-type="fig"}I and 3J). Thus, Shank proteins spatially restrict the endocytosis of mGluR5 to perisynaptic sites by coupling the EZ to the PSD.

The EZ Mediates Local mGluR5 Recycling {#sec2.4}
--------------------------------------

The reduction in EZ-associated synapses and the decrease in mGluR5 internalization in Shank knockdown neurons suggest that mGluR5 internalizes through the spine EZ coupled to the PSD via Shank intermediates. To further test whether mGluR5 can undergo recycling and whether this is facilitated by the EZ, we performed an antibody-based recycling assay to specifically label the recycled pool of receptors ([@bib29]). The levels of recycled mGluR5 were significantly higher at EZ^+^ PSDs, with almost no detectable recycling at EZ^−^ PSDs (30 min: EZ^+^: 1.2 ± 0.3, EZ^−^: 0.8 ± 0.2; 60 min: EZ^+^: 1.6 ± 0.2, EZ^−^: 0.9 ± 0.1, p \< 0.05; [Figures 3](#fig3){ref-type="fig"}K and 3L), consistent with the model that mGluR5 is internalized through the EZ to undergo local capture and recycling, reminiscent of AMPAR recycling ([@bib29]).

Shank Proteins Control Local Trafficking of mGluR5 in Spines {#sec2.5}
------------------------------------------------------------

We found that Shank knockdown specifically reduced the agonist-induced internalization of mGluR5 in spines, but not in dendrites, and predicted that disrupting the coupling between the EZ and the PSD would favor mGluR5 internalization at extrasynaptic sites. The density of internalized mGluR5 puncta at the dendritic shaft under basal conditions (t = 0 min) was similar in control and Shank knockdown neurons ([Figure S4](#mmc1){ref-type="supplementary-material"}A) and showed a similar increase 5 min after the application of DHPG ([Figures 4](#fig4){ref-type="fig"}A and 4B). However, 10 min after treatment with DHPG, the density of internalized mGluR5 puncta at the dendritic shaft was significantly increased in Shank knockdown neurons compared to t = 0 min (0 min: 1 ± 0.09, 10 min: 2.0 ± 0.2, p \< 0.001) and significantly different from control neurons (10 min: 1.2 ± 0.1, p = 0.01) ([Figures 4](#fig4){ref-type="fig"}A and 4B). This increase returned to control levels 20 min after treatment. Thus, in the absence of Shanks, activated receptors diffuse away from the synapse to internalize at extrasynaptic sites. This is expected to lead to a progressive reduction in surface mGluR5 levels at the synapse. Enrichment of SEP-mGluR5 in spines was significantly reduced in Shank knockdown neurons, and fully rescued by re-expression of Shank1, SHANK2, and SHANK3 (control: 1.5 ± 0.1, mirShank: 1.1 ± 0.04, Shank1: 1.4 ± 0.04, SHANK2: 1.5 ± 0.1, SHANK3: 1.4 ± 0.04, p \< 0.001; [Figure S4](#mmc1){ref-type="supplementary-material"}B). Immunoblotting showed no reduction in mGluR5 proteins levels in Shank knockdown neurons ([Figures S4](#mmc1){ref-type="supplementary-material"}C and S4D). However, the immunolabeling of mGluR5 showed that total levels of endogenous mGluR5 were reduced in Shank knockdown neurons (control: 1.0 ± 0.05, mirShank: 0.8 ± 0.03, p \< 0.01; [Figures S4](#mmc1){ref-type="supplementary-material"}E and S4F), which has been previously reported in Shank3 knockdown neurons ([@bib48]). Thus, disrupted mGluR5 recycling in Shank knockdown neurons leads to a reduction in the density of mGluR5 at the synaptic membrane.Figure 4Shanks Control mGluR5-Mediated Calcium Signaling and ERK1/2 Activity(A) Dendrite stained for internalized myc-mGluR5 at different time points after DHPG stimulation in control (gray outline; top panels) and mirShank (blue outline; bottom panels) neurons. Scale bar, 5 μm.(B) Quantification of internalized myc-mGluR5 puncta density in the dendritic shaft at different time points after DHPG stimulation in control (n = 18--24) and mirShank (n = 18--27) neurons, normalized to t = 0 per condition.(C) FRAP analysis of Venus-mGluR5 in spines of control (gray; n = 38 spines) and mirShank (blue; n = 38 spines) neurons.(D) Quantification of the mobile fraction of Venus-mGluR5 in spines of control and mirShank neurons.(E) Example of a dendrite expressing GCaMP6s stimulated with DHPG. Scale bar, 5 μm.(F) Oscillatory response of GCaMP6s signal in response to the application of DHPG (gray; n = 22) and DHPG + MPEP (orange; n = 26).(G) Quantification of the frequency (millihertz) of GCaMP6s oscillations in response to DHPG and DHPG + MPEP (n = 6).(H and I) Oscillatory response of GCaMP6s signal in response to DHPG in control (gray) (H) and mirShank (blue) (I) neurons.(J) Quantification of the frequency (millihertz) of GCaMP6s oscillations in response to DHPG in control (n = 20) and mirShank (n = 27) neurons.(K) Examples of control (top panels) and mirShank (bottom panels) neurons immunolabeled for anti-pERK1/2 in non-treated (NT) and treated neurons with DHPG for 10 min (10') or 30 min (30'). Orange arrowheads indicate the mCherry expressing control and mirShank neurons used for quantification. Scale bar, 50 μm.(L) Quantification of the average anti-pERK1/2 fluorescence intensity in the cell bodies of the transfected neurons of control (n = 17--24) and mirShank (n = 14--23) neurons with indicated treatment. Data are normalized to the average intensity of the NT control condition.Data are represented as means ± SEMs. ^∗^p \< 0.05, ^∗∗^p \< 0.01, and ^∗∗∗^p \< 0.001.

Shank proteins are large multi-domain scaffolding proteins and have been suggested to anchor mGluR5 at the synapse through interactions with Homer1b/c ([@bib47]). The reduced surface levels of mGluR5 in spines and the total levels of endogenous mGluR5 in Shank knockdown neurons could also be explained by a reduction in receptor binding sites at the PSD, modulating the stability of mGluR5. However, using fluorescence recovery after photobleaching (FRAP) experiments, we found that the rate of recovery and the total recovery of Venus-mGluR5 were similar in control and Shank knockdown neurons ([Figures 4](#fig4){ref-type="fig"}C and 4D), suggesting that Shank proteins do not directly contribute to the anchoring of mGluR5 at synaptic sites.

mGluR5-Mediated Calcium and ERK1/2 Signaling Is Abrogated in Shank Knockdown Neurons {#sec2.6}
------------------------------------------------------------------------------------

The density of mGluR5 on the membrane controls the activation of downstream signaling pathways ([@bib8], [@bib37]) that can trigger the oscillatory release of Ca^2+^ from internal stores ([@bib23]) and activate the extracellular signal-regulated kinase (ERK1/2) pathway ([@bib34]). To test the functional impact of the defect in mGluR5 trafficking in Shank knockdown neurons, we measured DHPG-induced Ca^2+^ oscillations using the fluorescent Ca^2+^ reporter GCaMP6s ([@bib7]). Consistent with previous reports, we found that DHPG triggered the immediate onset of robust Ca^2+^ oscillations ([Figures 4](#fig4){ref-type="fig"}E and 4F). DHPG-induced oscillations were completely blocked by the addition of the specific mGluR5 antagonist 2-methyl-6-(phenylethynyl)pyridine (MPEP) (DHPG: 17.3 ± 1.3 mHz and DHPG + MPEP: 3.5 ± 1.4 mHz, p \< 0.001; [Figures 4](#fig4){ref-type="fig"}F and 4G), confirming that these oscillations are mediated by the activation of mGluR5. We found that the frequency of DHPG-induced calcium peaks was significantly reduced in Shank knockdown neurons (control 21.6 ± 3.1 mHz, mirShank 12.6 ± 1.5 mHz, p \< 0.01; [Figures 4](#fig4){ref-type="fig"}H--4J). Furthermore, we compared DHPG-induced phosphorylation of ERK1/2 (pERK1/2) in control and Shank knockdown neurons. Incubation with DHPG for 10 and 30 min increased pERK1/2 shown by the immunolabeling of pERK1/2 in a population of control neurons, which was significantly reduced in Shank knockdown neurons after 30 min of DHPG treatment (10 min DHPG: control: 1.4 ± 0.15, mirShank: 0.95 ± 0.08; 30 min DHPG: control: 1.47 ± 0.16, mirShank: 0.89 ± 0.09, p \< 0.01; [Figures 4](#fig4){ref-type="fig"}K and 4L). Under basal conditions (non-treated \[NT\]) the levels of pERK1/2 were similar between control and Shank knockdown neurons (NT: control: 1.00 ± 0.10, mirShank: 0.94 ± 0.11; [Figures 4](#fig4){ref-type="fig"}J and 4K). These results indicate that Shank regulates mGluR5 signaling, substantiating an involvement of aberrant receptor trafficking in animal models of ASD with implicated deregulation of mGluR5 signaling.

Discussion {#sec3}
==========

Modulation of glutamatergic signaling by group I mGluRs is essential for proper synaptic transmission and plasticity, and deregulated mGluR signaling is broadly held to underlie the molecular pathology of neurodevelopmental disorders ([@bib30]). However, fundamental aspects of mGluR signaling and trafficking at excitatory synapses are still poorly understood. Here, we present a model in which coupling of the EZ to the PSD by Shank proteins enables local recycling of mGluRs, allowing the synapse to balance the density of mGluRs at the membrane to efficiently modulate neuronal functioning.

Our data show that Shank proteins selectively regulate activity-induced internalization of mGluR5 in spines. While DHPG-induced mGluR5 internalization is greatly affected in Shank knockdown neurons, in the absence of stimulation, the levels of mGluR5 remain relatively constant in both control and Shank knockdown neurons. This suggests that in the absence of Shanks, constitutive internalization of mGluR5 is not affected and continues to replace surface receptors. Thus, in the absence of efficient PSD-EZ coupling, synaptic receptors now escape this local endocytic sink and become internalized and recycled at extrasynaptic sites, slowly depleting the synaptic pool of receptors. We found a significant increase in agonist-induced mGluR5 internalization in dendrites and a significant decrease in surface mGluR5 levels in the spines of Shank knockdown neurons. This also suggests that dendritic internalization of mGluR5 is regulated independent of Shanks. Moreover, blocking Dynamin activity did not alter dendritic mGluR5 internalization, indicating that the internalization of dendritic receptors is regulated by different mechanisms. We consistently found a small reduction in SEP-mGluR5 signal in the absence of agonists, both in spines and dendrites. This could reflect the constitutive internalization of mGluR5, but ongoing recycling and lateral diffusion of receptors make it hard to interpret this directly. Nevertheless, previous studies found that mGluR5 undergoes constitutive internalization at a similar rate, but that this process is independent of clathrin and Dynamin activity ([@bib17]), and has been suggested to be mediated by the caveolin-mediated internalization pathway ([@bib18]). Our results are consistent with the notion that the EZ captures synaptic receptors through spatially restricted, clathrin-mediated endocytosis and recycling, allowing the synapse to autonomously control its receptor content ([@bib11]).

The reduction in surface mGluR5 levels in spines in Shank knockdown neurons was functionally reflected in a decrease in mGluR5-mediated calcium responses and ERK1/2 activation. Our experiments were focused on mGluR5, but we cannot exclude that other synaptic receptors or ion channels undergo aberrant trafficking when the EZ is uncoupled from the PSD. Glutamatergic transmission in general is reduced in Shank knockdown neurons ([@bib1], [@bib13], [@bib48]), Shank knockout mouse models ([@bib6], [@bib14], [@bib25], [@bib46]), and neurons expressing ASD-associated Shank mutations ([@bib27]). Thus, disrupting the link between the PSD and the EZ could have much broader effects on the composition of the synaptic membrane and glutamatergic transmission.

Our results indicate that all three Shank isoforms, which share a similar domain structure, recruit important components of the endocytic machinery to the PSD. The interaction between Shank and Homer1b/c confers a direct molecular link to the EZ through Dynamin3. Abrogating this interaction through directed mutation (our data) or through dominant-negative approaches ([@bib29]) significantly impairs EZ positioning. Shank proteins also seem to recruit Dynamin2 to the EZ, which likely provides the GTPase activity necessary for vesicle scission. We found that the Cortactin-binding motif in SHANK2 was also required for efficient mGluR5 internalization. Cortactin can also bind Dynamin2 and -3 directly ([@bib19]) and has been implicated in endocytosis and endolysomal sorting of AMPARs ([@bib40]). The expression of the Shank triple knockdown construct leads to a strong reduction in total Shank levels, but leaves ∼20% of total Shank levels intact ([@bib32]). Thus, we cannot exclude that remaining Shank proteins still recruit other interacting proteins that contribute to the trafficking of synaptic receptors.

Consistent with our results that Shank proteins control mGluR trafficking and function, recent studies show that deficits in social behavior caused by the loss of Shank function could be rescued by group I mGluR positive allosteric modulators ([@bib2], [@bib49]). However, even though deregulated receptor functioning at excitatory synapses has been implicated to underlie physiological deficits in many disease models, the molecular mechanisms underlying this have not been resolved. Our results indicate that Shank proteins do not directly anchor receptors at the synapse but provide a stable molecular framework that permits the local uptake and trafficking of receptors via the EZ, thereby governing a stable pool of synaptic receptors. That the ASD-associated T1127M mutation in SHANK2 disrupts this process further underlines the relevance of understanding the functional relation between Shank proteins and mGluR signaling in the context of human neurodevelopmental disorders.

STAR★Methods {#sec4}
============

Key Resources Table {#sec4.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Antibodies**Mouse anti-c-Myc (9E10) Monoclonal AntibodySanta Cruz BiotechnologyCat\# sc-40; RRID: [AB_627268](nif-antibody:AB_627268){#intref0010}Human anti-EEA1 Antibody (clone 4114)M. FritzlerN/ARabbit anti-mGluR5 AntibodyMilliporeCat\# 06-451; RRID: [AB_2313604](nif-antibody:AB_2313604){#intref0015}Rabbit anti-phospho-ERK1/2 AntibodyCell SignalingCat\# 9101; RRID: [AB_331646](nif-antibody:AB_331646){#intref0020}Mouse anti-PSD-95 AntibodyNeuromabCat\# 75-028; RRID: [AB_2292909](nif-antibody:AB_2292909){#intref0025}Mouse anti-Clathrin Heavy Chain (X22) Monoclonal AntibodyThermo Fisher ScientificCat\# MA1-065; RRID: [AB_2083179](nif-antibody:AB_2083179){#intref0030}Rabbit anti-Homer1 AntibodySynaptic SystemsCat\# 160 006; RRID: [AB_2631222](nif-antibody:AB_2631222){#intref0035}Mouse anti-alpha-tubulinSigma-AldrichCat\# T6074; RRID: [AB_477582](nif-antibody:AB_477582){#intref0040}Goat anti-Human IgG (H+L) Secondary Antibody, Alexa Fluor 568Thermo Fisher ScientificCat\# A-21090; RRID: [AB_2535746](nif-antibody:AB_2535746){#intref0045}Goat anti-Mouse IgG (H+L) Secondary Antibody, Alexa Fluor 647Thermo Fisher ScientificCat\# A-21236; RRID: [AB_2535805](nif-antibody:AB_2535805){#intref0050}Goat anti-Mouse IgG (H+L) Secondary Antibody, Alexa Fluor 488Thermo Fisher ScientificCat\# A-11029; RRID: [AB_2534088](nif-antibody:AB_2534088){#intref0055}Goat anti-Rabbit IgG (H+L) Secondary Antibody, Alexa Fluor 488Thermo Fisher ScientificCat\# A-11034; RRID: [AB_2576217](nif-antibody:AB_2576217){#intref0060}Swine anti-mouse HRP-conjugatedAgilentCat\# P0260; RRID: [AB_263692](nif-antibody:AB_263692){#intref0065}Goat Anti-Rabbit IgG Secondary Antibody, IRDye 680LTLI-COR BiosciencesCat\# 827-11081; RRID: [AB_10795015](nif-antibody:AB_10795015){#intref0070}Goat Anti-Mouse IgG Secondary Antibody, IRDye 800CWLI-COR BiosciencesCat\# 827-08364; RRID: [AB_10793856](nif-antibody:AB_10793856){#intref0075}**Bacterial and Virus Strains***Escherichia coli*: BL21DE3N/AN/A**Chemicals, Peptides, and Recombinant Proteins**Lipofectamine 2000Thermo Fisher ScientificCat\# 11668019(S)-3,5-DHPGTocrisCat\# 805DynasoreTocrisCat\# 2897MPEP hydrochlorideTocrisCat\# 1212Tetrodotoxin citrateTocrisCat\# 1069Polyvinyl alcohol mounting medium with DABCO®, antifading (Mowiol)Sigma AldrichCat\# 10981HaloTag® AcidiFluorORANGE LigandGORYO ChemicalCat\# GC310-01**Experimental Models: Cell Lines**Human embryonic kidney 239T (HEK293T)ATCCCat\# CRL-3216; RRID: CVCL_0063**Experimental Models: Organisms/Strains**Rattus norvegicus (Wistar; HanRj:WI)RGD, Janvier labsCat\# 13792727; RRID: RGD_13792727**Oligonucleotides**See [Table S1](#mmc1){ref-type="supplementary-material"} for miRNA targeting sequences of Shank1, 2 and 3N/AN/AΔPDZ: deleted Thr254 -- Thr348 with forward primer: ATTATTGAGGAGAAGAGGAATCTGGAC\
CCCGThis paperN/AΔPDZ: deleted Thr254 -- Thr348 with reverse primer: CTTCTCCTCAATAATGCAGTCAThis paperN/AΔDYN: deleted Glu1114 -- Ser113 with forward primer: TTTGACGCCGTCGCCGACTCTGGGATC\
GAGACCCTGTCTTCCGAAGGTGThis paperN/AΔDYN: deleted Glu1114 -- Ser113 with reverse primer: CACATTCTCTCCACCTTCGGAAGACAG\
GGTCTCGATCCCAGAGTCGGThis paperN/AT1127M: mutagenesis with forward primer: AGCG\
ACCACCACCTCGAGATGACCAGCACTATCTCC\
ACCGThis paperN/AT1127M: mutagenesis with reverse primer: CGGT\
GGAGATAGTGCTGGTCATCTCGAGGTGGTGGT\
CGCTThis paperN/AL1008P1009: duplication with forward primer: GTGATTTTGCCATTGCCATTCCGCATCCCTCCThis paperN/AL1008P1009: duplication with reverse primer: GGG\
ATGCGGAATGGCAATGGCAAAATCACCGCThis paperN/A**Recombinant DNA**pRK5-Venus-mGluR5aDr. J. PerroyN/ApRK5-SEP-mGluR5aThis paperN/ApRK5-myc-mGluR5aThis paperN/ApRK5-Halo-mGluR5aThis paperN/ApRK5-SEP-mGluR1This paperclone image ID \# 40080840pSM155-Cer3[@bib32]N/ApSM155-mCherryThis paperN/ApSM155-GFP[@bib32]N/ApSM155-mirShank::Cer3[@bib32]N/ApSM155-mirShank::mCherryThis paperN/ApSM155-mirShank::GFP[@bib32]N/ApSM155-mirShank::mCherry-Shank1This paperN/ApSM155-mirShank::mCherry-SHANK2This paper and [@bib32]N/ApSM155-mirShank::mCherry-SHANK3This paperN/ApSM155-mirShank::mCherry-SHANK2-ΔPDZThis paperN/ApSM155-mirShank::mCherry-SHANK2-ΔDYNThis paperN/ApSM155-mirShank::mCherry-SHANK2-ΔCORThis paper and [@bib32]N/ApSM155-mirShank::mCherry-SHANK2-P1035LThis paper and [@bib32]N/ApSM155-mirShank::mCherry-SHANK2-T1127MThis paperN/ApSM155-mirShank::mCherry-SHANK2-LpdupThis paperN/ApcDNA3.1- mCherry-Shank2Dr. Simone Berkel ([@bib4])N/AmCherry-Shank3Dr. M. Schmeisser ([@bib9])N/ApEGFP-C2-GFP-Clathrin-light-ChainDr. Mike EhlerspmCherry-N1-Homer1c-mCherry[@bib31]N/AGFP-Rab5[@bib21]N/AGFP-Rab11[@bib15]N/ATfR-SEP[@bib21]N/AGFP-Rab7[@bib21]N/ApEGFP-N3-LAMP1-mGFPDr. Esteban Dell'Angelica ([@bib16])<http://addgene.org/34831>; RRID: Addgene_34831pEGFP-N1-Dynamin2-GFPDr. Pietro De Camilli ([@bib38])N/ApEGFP-N1-Dynamin2-K44A-GFPDr. Pietro De Camilli ([@bib38])<http://addgene.org/22301>; RRID: Addgene_22301pGP-CMV-GcaMP6sDr. Douglas Kim ([@bib7])<http://addgene.org/40753>; RRID: Addgene_40753pCAG_PSD95.FingR-eGFP-CCR5TCDr. Don Arnold ([@bib20])<http://addgene.org/46295>; RRID: Addgene_46295FUGWDr. David Baltimore<http://addgene.og/14883>; RRID: Addgene_14883FUGW-mirShank-GFPThis paperN/Ap.MDG2Didier Trono<http://addgene.org/12259>; RRID: Addgene_12259psPAX2Didier Trono<http://addgene.org/12260>; RRID: Addgene_12260**Software and Algorithms**ImageJNIH<https://imagej.nih.gov/ij/>; RRID: [SCR_003070](rridsoftware:SCR_003070){#intref0120}FijiFiji<http://fiji.sc>; RRID: [SCR_002285](rridsoftware:SCR_002285){#intref0130}GraphPad Prism 8GraphPad<https://www.graphpad.com/scientific-software/prism/>; RRID: [SCR_002798](rridsoftware:SCR_002798){#intref0140}Adobe Illustrator CC 2017Adobe<https://www.adobe.com/products/illustrator.html>; RRID: [SCR_010279](rridsoftware:SCR_010279){#intref0150}MATLAB 2018aMATLAB<https://www.mathworks.com/products/matlab/>; RRID: [SCR_001622](rridsoftware:SCR_001622){#intref0160}

Lead Contact and Materials Availability {#sec4.2}
---------------------------------------

Plasmids generated in this study are available on request. Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Harold MacGillavry (<h.d.macgillavry@uu.nl>).

Experimental Model and Subject Details {#sec4.3}
--------------------------------------

### Animals {#sec4.3.1}

All animal experiments were performed in compliance with the guidelines for the welfare of experimental animals issued by the Government of the Netherlands (Wet op de Dierproeven, 1996) and European regulations (Guideline 86/609/EEC). All animal experiments were approved by the Dutch Animal Experiments Review Committee (Dier Experimenten Commissie; DEC), performed in line with the institutional guidelines of Utrecht University.

### Primary Neuronal Cultures and Transfections {#sec4.3.2}

Hippocampal cultures were prepared from embryonic day 18 (E18) Janvier Wistar rat brains (both genders) as described in [@bib10]. Dissociated neurons were plated on coverslips coated with poly-L-lysine (37.5 μg/ml, Sigma-Aldrich) and laminin (1.25 μg/ml, Roche Diagnostics) at a density of 100,000 neurons per well of a 12-well plate. Cultures were grown in Neurobasal medium (NB) supplemented with 2% B27 (GIBCO), 0.5 mM glutamine (GIBCO), 15.6 μM glutamate (Sigma-Aldrich), and 1% penicillin/ streptomycin at 37**°**C in 5% CO~2~. At DIV14-18 neurons were transfected with indicated constructs using Lipofectamine 2000 (Invitrogen). Before transfection 260 μl conditioned medium was transferred to a new culture plate and replaced with 260 μl NB with 0.5 mM glutamine. For each well, 1.8 μg DNA was mixed with 3.3 μl Lipofectamine 2000 in 200 μl NB, incubated for 30 min at RT and added to the neurons. After 45 -- 60 minutes, neurons were briefly washed with NB and transferred to the new culture plate with conditioned medium supplemented with 260 μl NB with B27, glutamine, penicillin/ streptomycin and kept at 37**°**C in 5% CO~2~ for 2-4 days (for overexpression) or 5-7 days (for Shank knockdown).

Method Details {#sec4.4}
--------------

### DNA Constructs {#sec4.4.1}

The pRK5-SEP-mGluR5a, pRK5-Halo-mGluR5a and pRK5-myc-mGluR5a constructs were made using the pRK5-Venus-mGluR5a construct (a gift from Dr. Julie Perroy) as a template and the pRK5-SEP-mGluR1 construct was made by replacing mGluR5a with mGluR1 (clone image ID \# 40080840). The human mCherry-SHANK2 expression plasmid was kindly provided by [@bib4]. The pSM155-GFP (or Cerulean3; Cer3), Shank triple-knockdown construct pSM155-mirShank-GFP (or Cer3), and mirShank::GFP-SHANK2 wild-type (:: to indicate that the Shank miRNAs and GFP-tagged human SHANK2 are expressed simultaneously from a single expression cassette), mirShank::GFP-SHANK2-ΔCOR, and mirShank::GFP-SHANK2-P1035L mutant rescue constructs are described in [@bib32]. In these constructs GFP was replaced by mCherry (from pmCherry-N1, Invitrogen). To make the mirShank::mCherry-SHANK2-ΔDYN (lacking the 25-amino acid dynamin-binding domain; Glu1114 - Ser1138) ([@bib39]), mirShank::mCherry-SHANK2-ΔPDZ (lacking the 95-amino acid PDZ domain, Thr254 - Thr348), mirShank::mCherry-SHANK2-L1008P1009dup and mirShank::mCherry-SHANK2-T1127M constructs, primers were designed containing the desired mutations and 10 -- 15 bp overhangs for Gibson assembly (NEBuilder HiFi DNA assembly cloning kit). The rat Shank1 and human SHANK3 expression plasmids were a gift from Dr. Morgan Sheng and Dr. Michael Schmeisser ([@bib9]), respectively, and used as a template to make the pSM155-mirShank::mCherry-Shank1 and pSM155-mirShank::mCherry-SHANK3 rescue constructs. Dynamin2-GFP and Dynamin2-K44A-GFP (Addgene plasmid \# 22301) were a gift from Dr. Pietro De Camilli ([@bib38]), and in both constructs GFP was replaced by mCherry. GFP-CLC (rat clathrin light chain A1) was a gift from Dr. Mike Ehlers, LAMP1-GFP was a gift from Dr. Esteban Dell'Angelica (Addgene plasmid \# 34831) ([@bib16]), and pGP-CMV-GCaMP6s was a gift from Dr. Douglas Kim (Addgene plasmid \# 40753) ([@bib7]). pCAG-PSD95.FingR-eGFP-CCR5TC (PSDFingR-GFP) was a gift from Dr. Don Arnold (Addgene plasmid \# 46295) ([@bib20]). The following constructs have been described before: Homer1c-mCherry ([@bib31]), GFP-Rab5, GFP-Rab7, mRFP-TfR ([@bib21]), and tdTomato-Rab11 ([@bib15]). FUGW was a gift from David Baltimore (Addgene plasmid \# 14883) ([@bib28]). FUGW-mirShank-GFP was generated by replacing GFP with the Shank triple-knockdown cassette from pSM155-mirShank-GFP. All constructs were verified by sequencing.

Lentiviral particles were generated by transfecting the transfer plasmid together with the packaging plasmids p.MDG2 (Addgene plasmid \#12259) and psPAX2 (Addgene plasmid \#12260) (gifts from Didier Trono) in HEK293T cells. The supernatant was collected two days after transfection and concentrated using tangential flow filtration (Amicon Ultra spin filters, Millipore \#UFC910024).

### Confocal Imaging {#sec4.4.2}

Confocal images were taken with a Zeiss LSM 700 confocal laser-scanning microscope with a Plan-Apochromat 63x NA 1.40 oil objective. Images consist of a z stack of 7-9 planes at 0.39 μm interval, and maximum intensity projections were generated for analysis and display. The pERK1/2 ([Figures 4](#fig4){ref-type="fig"}J and 4K) and anti-mGluR5 ([Figure S4](#mmc1){ref-type="supplementary-material"}B and S4C) images were taken with an EC Plan-Neofluar 40x NA 1.30 oil objective and consist of a z stack of 9 planes at 0.67 μm interval to obtain maximum intensity projections of the entire neuron in the z axis.

### Antibody Feeding Assay {#sec4.4.3}

DIV18 neurons were transfected with myc-mGluR5 and endosomal markers as indicated and were live-labeled at DIV21 with mouse anti-c-*myc* (9E10, Santa Cruz Biotechnology, catalog \# sc-40) diluted 1:200 in extracellular imaging buffer (120 mM NaCl, 3 mM KCl, 2 mM CaCl~2~, 2 mM MgCl~2~, 10 mM glucose, and 10 mM HEPES, pH adjusted to 7.35 with NaOH) for 30 minutes at RT, washed twice with imaging buffer, and incubated with 50 μM DHPG (Tocris) for the indicated time-points at 37°C. Cells were then fixed in 4% (w/v) paraformaldehyde (PFA) and 4% (w/v) sucrose in PBS for 10 minutes at RT, and washed three times with PBS supplemented with 100 mM glycine (PBS/Gly). To label the surface-expressed pool of receptors, cells were incubated with goat anti-mouse Alexa-647 (Thermo Fisher Scientific) diluted 1:200 in 5% (v/v) NGS in PBS/Gly for 30 minutes at RT, and washed three times with PBS/Gly. Then, to label the intracellular pool of receptors, cells were permeabilized with 0.25% (v/v) Triton X-100 and 5% (v/v) NGS in PBS/Gly for 5 minutes at RT, blocked with 10% (v/v) NGS in PBS/Gly for 30 minutes, and incubated with goat anti-mouse Alexa 488 (Thermo Fisher Scientific) diluted 1:200 in 5% (v/v) NGS in PBS/Gly for 30 minutes at RT. For co-labeling internalized mGluR5 with EEA1, cells were incubated with human anti-EEA1 (clone 4114; gift from M. Fritzler) diluted 1:500 in 5% (v/v) NGS in PBS/Gly for 2 hours at RT after the permeabilization and blocking steps, and detected with goat anti-human Alexa-568 (Thermo Fisher Scientific). Cells were washed three times with PBS/Gly, mounted in Mowiol mounting medium and imaged on a confocal system as described above.

For the Shank knockdown experiments DIV14 neurons were transfected with pSM155-Cer3 or mirShank::Cer3 together with myc-mGluR5 and Homer1c-mCherry. For the rescue experiments DIV14 neurons were transfected with indicated mirShank::mCherry-SHANK rescue constructs and myc-mGluR5. After 7 days (DIV21), neurons were live-labeled with anti-myc, stimulated with DHPG for 30 minutes, and the surface and internalized pools of myc-mGluR5 were visualized as described above.

For the density of internalized mGluR5 puncta in the dendritic shaft after treatment with DHPG for several points before fixation, DIV14 neurons were transfected with pSM155-mCherry or mirShank::mCherry and myc-mGluR5. After 7 days (DIV21), neurons were live-labeled with anti-myc, stimulated with DHPG for 0, 2, 5, 10 or 20 minutes, and the surface and internalized pools of myc-mGluR5 were visualized as described above.

### Endocytic Zone Associated PSDs {#sec4.4.4}

For the Shank knockdown experiments DIV14 neurons were transfected with pSM155-Cer3 or mirShank::Cer3 together with GFP-CLC and Homer1c-mCherry. Alternatively, pSM155-Cer3 or mirShank::Cer3 transfected neurons were stained for endogenous clathrin with mouse anti-clathrin heavy chain (clone X22, Fisher Scientific) and Homer1, with rabbit anti-Homer1 (SySy), and visualized with goat anti-mouse Alexa-647 and goat anti-rabbit Alexa 488 antibodies. For the rescue experiments DIV14 neurons were transfected with indicated mirShank::mCherry-SHANK rescue constructs and GFP-CLC. After 7 days (DIV21), neurons were fixed with 4% PFA and 4% sucrose in PBS for 15 minutes, washed, mounted in Mowiol mounting medium and imaged on a confocal system as described above.

For the co-localization between the PSD and Homer1c in control and Shank knockdown neurons, DIV14 neurons were transfected with pSM155-Cer3 or mirShank::Cer3 together with Homer1c-mCherry and PSDFingR-GFP. For the rescue experiments DIV14 neurons were transfected with indicated mirShank::mCherry-SHANK2 rescue constructs and PSDFingR-GFP. After 7 days (DIV21) the neurons were fixed, mounted and imaged as described above.

### Receptor Recycling Assay {#sec4.4.5}

Neurons were live labeled with anti-myc 1:200 in extracellular imaging buffer for 30 minutes at RT, washed twice with imaging buffer, and incubated with 50 μM DHPG for 30 minutes at 37°C to induce receptor internalization. Remaining surface-bound anti-myc antibodies were blocked by incubating with HRP-conjugated swine anti-mouse (Agilent) antibodies diluted 1:100 for 30 minutes at RT. Cells were then washed twice and returned to 37**°**C to allow receptor recycling for the indicated time points. The recycled receptor pool was then labeled with goat anti-mouse Alexa-647 diluted 1:200 in 5% (v/v) NGS in PBS/Gly for 30 minutes at RT. Cells were washed three times with PBS/Gly, mounted in Mowiol mounting medium and imaged on a confocal system as described above.

### Endogenous mGluR5 Protein Levels {#sec4.4.6}

DIV14 neurons were transfected with pSM155-mCherry or mirShank::mCherry and stained for endogenous surface and intracellular mGluR5 with rabbit anti-mGluR5 (Chemicon, catalog \#ab5675) diluted 1:500 in 0.1% (v/v) Triton X-100 and 5% (v/v) NGS in PBS/Gly overnight at 4**°**C, and visualized with goat anti-rabbit Alexa 488 diluted 1:250 in 0.1% (v/v) Triton X-100 and 5% (v/v) NGS in PBS/Gly for 1 hour at RT. Cells were washed three times with PBS/Gly, mounted in Mowiol mounting medium and imaged on a confocal system as described above.

### ERK1/2 Phosphorylation Assay {#sec4.4.7}

Neurons were transfected with pSM155-mCherry or mirShank::mCherry at DIV14. Tetrodotoxin (2 μM; TTX) was added 12 hours before treatment. At DIV22 neurons were incubated with either 100 μM DHPG diluted in extracellular imaging buffer for 10 or 30 minutes, or with extracellular imaging buffer only for non-treated control neurons. After the indicated time points the neurons were fixed in 4% PFA and 4% sucrose in PBS for 10 minutes at RT, followed by a quick wash with PBS/Gly, incubated with ice cold methanol (MeOH) for 10 minutes at −20**°**C and washed three times with PBS/Gly. The pSM155-mCherry or mirShank::mCherry transfected neurons were stained for ERK1/2 phosphorylation with rabbit anti-pERK1/2 (Cell Signaling, catalog \#9101) diluted in 0.1% (v/v) Triton X-100 and 5% (v/v) NGS in PBS/Gly overnight at 4**°**C, and visualized with goat anti-rabbit Alexa-A488 diluted in 0.1% (v/v) Triton X-100 and 5% (v/v) NGS in PBS/Gly for 1 hour at RT. Cells were washed three times with PBS/Gly, mounted in Mowiol mounting medium and imaged on a confocal system as described above.

### Live-Cell Imaging {#sec4.4.8}

Live-cell imaging was performed on a spinning disk confocal system (CSU-X1-A1; Yokogawa) mounted on a Nikon Eclipse Ti microscope (Nikon) with Plan Apo VC 100x 1.40 NA, or Plan Apo 60x 1.30 NA oil objectives (Nikon) with excitation from Cobolt Calyspso (491 nm), and Jive (561 nm) lasers, and emission filters (Chroma). The microscope was equipped with a motorized XYZ stage (ASI; MS-2000), Perfect Focus System (Nikon), Evolve 512 EM-CCD camera (Photometrics), and was controlled by MetaMorph 7.7.6 software (Molecular Devices). Neurons were maintained in a closed incubation chamber (Tokai hit: INUBG2E-ZILCS) at 37**°**C in 5% CO~2~ in extracellular imaging buffer.

### Live-Cell Imaging of SEP-Tagged mGluR5 {#sec4.4.9}

DIV14 neurons were transfected with SEP-mGluR5 or SEP-mGluR1 together with pSM155-mCherry, mirShank::mCherry, mirShank::mCherry-Shank1 rescue, mirShank::mCherry-SHANK2 rescue, mirShank::mCherry- SHANK3 rescue or mCherry-Shank2 overexpression constructs. After 7 days, live neurons were imaged on a spinning disk confocal system (described above). After a 2-minute base-line acquisition, internalization was induced by the addition of DHPG to a final concentration of 50 μM and the SEP-mGluR5 signal was imaged every 30 s for 30 minutes (61 frames) using the 491 nm excitation laser. Dynasore (100 μM; Tocris) was added 2 minutes before acquisition. In the vehicle control extracellular imaging buffer was added to the incubation chamber after a 2-minute base-line acquisition in the same volume (40 μl to 360 μl) as DHPG. To control for photobleaching the SEP-mGluR5 signal was imaged every 5 minutes for 30 minutes (7 frames). Multiple Z stacks (10 planes) were obtained, with 0.5 μm intervals to acquire 4.5 μm image stacks.

### SEP pH Sensitivity Assay {#sec4.4.10}

DIV18 neurons were transfected with SEP-mGluR5 and imaged at DIV21 on a spinning disk confocal system (described above). First, neurons were maintained in extracellular imaging buffer with pH 7.35 to visualize the mGluR5 surface pool. Then, the buffer was exchanged for imaging buffer with pH 5.5 (identical to extracellular imaging buffer, except 10 mM HEPES was replaced by 15 mM MES). Then, the low-pH buffer was exchanged for a buffer with pH 7.35 containing ammonium chloride (NH~4~Cl) (identical to extracellular imaging buffer, except for 70 mM NaCl, 50 mM NH~4~Cl and 2 mM NaHCO~3~ instead of 120 mM NaCl). To evaluate the change in fluorescence upon exchanging the buffers, each neuron was imaged consecutively for all three conditions and 6 time points at 30 s intervals were obtained per condition. Multiple Z stacks (10 planes) were obtained, with 0.5 μm intervals to acquire 4.5 μm image stacks per time point. For analysis, MAX intensity projections were used to assess the SEP-mGluR5 intensity for all 6 time points per condition and the change in fluorescence over time and different conditions was plotted.

### Live-Cell Imaging of AcidiFluor ORANGE Halo-Tagged mGluR5 {#sec4.4.11}

DIV18 neurons were transfected with Halo-mGluR5 and psm155-GFP, and imaged at DIV21 on a spinning disk confocal system (described above). Surface Halo-mGluR5 was labeled with 1.5 μM HaloTag AcidiFluor ORANGE (Goryo Chemical, cat\#-GC310) for 20 minutes at 37**°**C in 5% CO~2~. Neurons were rinsed in extracellular imaging buffer to remove unbound dye. Halo-mGluR5 labeled with AcidiFluor ORANGE was imaged in extracellular imaging buffer at 100 ms exposure and 2 s interval for 5 minutes using the 561 excitation laser. Timelapses were taken of a single z-plane. After a 40 s baseline acquisition, internalization was induced by the application of DHPG to a final concentration of 100 μM. Then, after 280 s, imaging buffer was exchanged for a buffer with pH 7.35 containing NH~4~Cl (described above) to quench the signal of internalized Halo-mGluR5 AcidiFluor ORANGE. Also, a Z stack (10 planes) was obtained, with 0.5 μm intervals to acquire 4.5 μm image stacks of psm155-GFP, which was co-transfected for quantification purposes.

### Fluorescence Recovery after Photobleaching {#sec4.4.12}

For fluorescence recovery after photobleaching (FRAP) experiments, DIV14 neurons were transfected with Venus-mGluR5 and pSM155-mCherry or mirShank::mCherry, and imaged on a spinning disk confocal system (described above). FRAP experiments were performed using the ILas2 system (Roper Scientific). Individual spines were photobleached with a targeted 491 nm laser and imaged every 5 seconds for fluorescence recovery for a period of 5 minutes.

### Calcium Imaging {#sec4.4.13}

DIV14 neurons were transfected with GCaMP6s together with pSM155-mCherry or mirShank::mCherry and imaged 5 -- 7 days later. Calcium imaging was performed on a spinning disk confocal system (described above). GCaMP6s signal was imaged at 2 s intervals (0.5 Hz) with a z stack stream (3 - 5 planes) at every time point. After 5 minutes baseline imaging, DHPG was added to 100 μM final concentration, and cells were imaged for another 5 - 10 minutes. MPEP (5 μM; Tocris) was added 5 minutes after application of DHPG.

### Western Blot and Imaging {#sec4.4.14}

DIV10 neurons were infected with FUGW or FUGW-mirShank lentivirus for 10 days. Neurons were directly lysed in SDS sample buffer containing DTT. Lysates were subjected to Tris-Glycine SDS-PAGE followed by transfer on PVDF membranes. Blots were blocked in 2% BSA in PBS-T (0.05% Tween20) followed by primary and IRDye-conjugated secondary antibody incubation (in 2% BSA in PBS-T). Western blots were scanned using Odyssey infrared imaging system (Li-COR Biosciences).

Quantification and Statistical Analysis {#sec4.5}
---------------------------------------

### Quantification of Endocytic Zone Associated PSDs {#sec4.5.1}

To quantify the fraction of synapses with an associated endocytic zone, circular regions with a fixed diameter (0.69 μm) were centered on the Homer1c-mCherry or mCherry-SHANK2 clusters to indicate synaptic regions. These regions were then transferred to the GFP-CLC or anti-clathrin channel. A synapse was classified EZ-positive if the clathrin cluster overlapped partially or completely with the circular region. The fraction of EZ-positive synapses was calculated per neuron and averaged per condition over the total population of neurons. Furthermore, the density of clathrin puncta was determined along the dendrite (per 10 μm).

To quantify the percentage of PSDFingR-GFP puncta overlapping with indicated mCherry constructs, puncta were selected with circular regions in the mCherry channel and transferred to the PSDFingR-GFP channel. It was classified as overlapping if the PSDFingR cluster overlapped partially or completely with the circular region. Furthermore, the puncta density of the indicated mirShank::mCherry-SHANK2 rescue constructs was determined along the dendrite (per 20 μm).

### Quantification of Internalized mGluR5 Puncta in Spines and Dendrites {#sec4.5.2}

The number of PSDs associated with an internalized mGluR5 puncta was determined similar as the fraction of endocytic zone positive PSDs.

The density of internalized mGluR5 puncta in the dendritic shaft was determined by semi-automatic quantification. The dendritic shaft (20 μm in length) was selected and a threshold was set for each image. The selection was converted to an inverted binary image and a particle analysis was used to detect internalized mGluR5 puncta with a minimum size of 0.01 μm^2^. The baseline condition (t = 0) was similar between control and Shank knockdown neurons. Therefore, to show the relative increase in internalized mGuR5 puncta in the dendritic shaft over time the treatment conditions were normalized per batch to the average density of its corresponding baseline condition.

### Quantification of SEP-mGluR5 Internalization in Spines and Dendrites {#sec4.5.3}

MAX intensity projections of the Z stacks were obtained and corrected for XY drift over time using the Fiji plugin "StackReg." To quantify the SEP-mGluR5 intensity over a time-period of 30 minutes circular regions of interest (spines or dendrites) were selected at t = −2 and the intensity was measured for all 61 time points. To obtain the change in relative fluorescence intensity (ΔF/F~0~) over time, background was subtracted and the intensity relative to t = −2 was computed. For visualization all values were subtracted by 1 and plotted at 1 minute intervals.

### Quantification of AcidiFluor ORANGE Halo-Tagged mGluR5 Acidification in Spines and Dendrites {#sec4.5.4}

MAX intensity projections of the psm155-GFP Z stacks were made and used to trace the neuron using Fiji software. This selection was then transferred to the AcidiFluor ORANGE Halo-mGluR5 channel to clearly indicate the outline of the neuron. A Gaussian blur (sigma = 2) was applied to the AcidiFluor ORANGE images, and a total of 6 neurons from 2 batches were manually screened for acidification events. To test the pH sensitivity of AcidiFluor ORANGE, imaging buffer was exchanged for a buffer containing NH~4~Cl which quenched the signal. Representative images are shown at 4-10 s intervals. To visualize the change in relative fluorescence intensity over time, values were plotted as ΔF/F~0~ for the spine and dendrite.

### Quantification of Spine Enrichment {#sec4.5.5}

To assess the spine enrichment of surface mGluR5, the SEP-mGluR5 intensity at t = −2 min from the live-cell base-line acquisition was quantified in control, mirShank and mirShank::Shank1, mirShank::SHANK2 and mirShank::SHANK3 rescue neurons as relative spine intensity over relative dendritic shaft intensity. For each neuron circular regions were traced on multiple dendritic spines to measure spine intensity and for each selected spine a circular region in the dendrite at the base of the spine was measured as dendritic shaft intensity. Background intensity was subtracted.

### Quantification of Immunofluorescence of Endogenous mGluR5 {#sec4.5.6}

For the analysis of endogenous total mGluR5 levels a dendritic stretch of 20 μm was selected and traced in the mCherry channel using Fiji software. This selection was then transferred to the anti-mGluR5 channel and the average intensity of the anti-mGluR5 fluorescence of the transfected neurons with indicated constructs was obtained. Per batch the average intensity was normalized to the average intensity of the control neurons.

### Quantification of FRAP Experiment {#sec4.5.7}

For FRAP analysis, the mean intensity of the bleached area was corrected for background values, as well as the bleaching that occurred during image acquisition. Data were normalized to control fluorescence averaged over 5 frames before bleaching. Individual recovery curves were fitted with a single-exponential function *I = A(1 -- exp(-Kt))* to estimate the mobile fraction (*A*) and time constant tau.

### Quantification of Calcium Experiment {#sec4.5.8}

For each neuron, the fluorescence intensity of GCaMP6s signal was measured in 10 - 20 ROIs along the dendrite, background subtracted and averaged. To obtain the mean amplitude and frequency of the calcium oscillations, events were detected with the MATLAB 'PeakFinder' function.

### Quantification of ERK1/2 Phosphorylation Assay {#sec4.5.9}

For analysis the cell bodies were manually traced based on the mCherry channel using Fiji software. The average intensity of the anti-pERK1/2 fluorescence of the transfected neurons with indicated constructs was obtained for each condition and was normalized per batch to the average intensity of the non-treated control condition.

### Statistical Analysis {#sec4.5.10}

Statistical significance was tested with a paired t test ([Figures 3](#fig3){ref-type="fig"}L and [4](#fig4){ref-type="fig"}G) or unpaired t test ([Figures 3](#fig3){ref-type="fig"}C, 3H, [4](#fig4){ref-type="fig"}D, [S3](#mmc1){ref-type="supplementary-material"}A, and [S4](#mmc1){ref-type="supplementary-material"}A, S4D, and S4F) when comparing two groups with a normal distribution and a Mann Whitney test when comparing two groups without a normal distribution ([Figures 4](#fig4){ref-type="fig"}J and [S3](#mmc1){ref-type="supplementary-material"}C). If multiple groups were compared ([Figures 1](#fig1){ref-type="fig"}D, [3](#fig3){ref-type="fig"}D, 3F, 3J, [S3](#mmc1){ref-type="supplementary-material"}G, S3H, S3J, and [S4](#mmc1){ref-type="supplementary-material"}B), statistical significance was tested with a one-way ANOVA followed by a Tukey's multiple comparison when comparing the mean of each column to the mean of every other column or a Dunnet's multiple comparison when comparing the mean of each column to the mean of a control column. When comparing multiple groups without a normal distribution, a Kruskall Wallis followed by a Dunn's multiple comparison was performed ([Figure S3](#mmc1){ref-type="supplementary-material"}F). To test for an effect of treatment over time between different groups with matched values in time ([Figures 1](#fig1){ref-type="fig"}G--1L, [2](#fig2){ref-type="fig"}B--2F, [S1](#mmc1){ref-type="supplementary-material"}B, S1C, S1I-- S1L, [S2](#mmc1){ref-type="supplementary-material"}C, and S2D), statistical significance was tested with a repeated-measures two-way ANOVA followed by a Tukey's multiple comparison when comparing more than two groups. To test for an effect of treatment over time between different groups without matched factors ([Figures 4](#fig4){ref-type="fig"}B and 4L), statistical significance was tested with a two-way ANOVA followed by a Tukey's multiple comparison when comparing more than two groups. The data table of [Figure 2](#fig2){ref-type="fig"}G contains some missing values, since during image acquisition some frames were out of focus and could not be taken into account for analysis, and a mixed effects ANOVA was performed. The effect was considered significant if the row factor (time or treatment), the column factor (condition) and the interaction (time x condition) effect were all significant (*P*-value below 0.05). In the text the *P*-values of the condition effects are reported. In the figures, ^∗^ indicates significance based on the condition effect and when comparing more than two groups, ^∗^ indicates significance based on the multiple comparison test. In all figures ^∗^ was used to indicate a *P*-value \< 0.05, ^∗∗^ for p \< 0.01, and ^∗∗∗^ for p \< 0.001. See [Table S2](#mmc1){ref-type="supplementary-material"} for all *P*-values and statistical tests performed. Data are represented as mean ± SEM. Reported *n* is number of neurons, which are indicated as scatters in the bar graphs. Each experiment was replicated in cultures from at least 2 independent preparations. Statistical analysis and graphs were prepared in GraphPad Prism and figures were generated in Adobe Illustrator CC.

Data and Code Availability {#sec4.6}
--------------------------

The published article includes all datasets generated or analyzed during this study.
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